Progress in the understanding of myasthenia gravis pathogenesis.
D000110:Acetylcholinesterase / Q000378:metabolism; D000818:Animals; D000906:Antibodies; D002800:Cholinesterase Inhibitors / Q000627:therapeutic use; D004681:Encephalomyelitis, Autoimmune, Experimental / Q000276:immunology; D006801:Humans; D009157:Myasthenia Gravis / Q000276:immunology* / Q000378:metabolism; D011950:Receptors, Cholinergic / Q000276:immunology*; D011978:Receptors, Nicotinic / Q000276:immunology*; D013601:T-Lymphocytes / Q000378:metabolism
D000906:Antibodies; D002800:Cholinesterase Inhibitors; D011950:Receptors, Cholinergic; D011978:Receptors, Nicotinic; D000110:Acetylcholinesterase